Pharmaceuticals
South Korea's Celltrion exports coronavirus tests to US
Diagnostic kits to help fill US testing gap
Diagnostic kits to help fill US testing gap
South Korean company predicts long-term growth in contract drugmaking business
Tokyo's second deal, after Pfizer agreement, diversifies early-stage supply
Japanese group ties up with US biotech company for late-stage trial
UK company expects to begin Japan tests in August
Singapore tightens rules on travelers from Japan, Hong Kong
Sovereign fund leads UK Glympse Bio's $46.7m fundraising
Relay Therapeutics jumps 75% in Nasdaq debut
Smaller nations join forces to match US-China purchasing power
Drugmaker's two plants can produce 200m doses as candidate moves through trials
Stay ahead with our exclusives on Asia;
the most dynamic market in the world.
Stay ahead with our exclusives on Asia
Get trusted insights from experts within Asia itself.
Get trusted insights from experts
within Asia itself.
Stay ahead with our exclusives on Asia; the most dynamic market in the world.
Get trusted insights from experts
within Asia itself.
Offer ends January 31st
You need a subscription to...
You need a subscription to:
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.